We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Western Norway Mental Health Interface Study on Referral Letters

This study is ongoing, but not recruiting participants.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01374035
First Posted: June 15, 2011
Last Update Posted: March 18, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
University of Bergen
Katholieke Universiteit Leuven
Information provided by:
Helse Fonna
  Purpose
The main object to this trial is to study the function of referral letters as a mean to coordinate the care process for adult people when referred from Primary Care to Specialised Mental Health Care. The study will explore if and to what degree the quality of these referral letters can be improved, and the potential improvement's impact on defined patient-, professional and organisational related outcomes. According to Medical Research Council guidelines for evaluating complex interventions, a stepwise design with the use of both qualitative and quantitative methods will be used to conduct a controlled intervention study.

Condition Intervention
Mental Disorders Other: Quality improvement intervention

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Health Services Research
Official Title: Interface Between Primary Care and Specialist Mental Health Care - the Referral Letters

Resource links provided by NLM:


Further study details as provided by Helse Fonna:

Primary Outcome Measures:
  • Length of stay [ Time Frame: Day of discharge assessed up to six months ]
    From date of admission or onset of out-patient treatment until date of discharge (documented in Electronic Patient Record as end of treatment periode), assessed up to six months from admission.


Secondary Outcome Measures:
  • Response time for referral letters in Specialised Mental Health Care [ Time Frame: Referral letters will be followed for the duration of the assessment and prioritation process until response letter is sent, an expected avarage of 10 days. ]
    Unit of measure: Number of days from receiving a referral letter to the response letter is sent to the patient and the General Practitioner. The response time for all letters recieved in a six month periode before the intervention to improve the quality of referral letters will be compared with the response time after the intervention.


Estimated Enrollment: 100
Study Start Date: August 2010
Estimated Study Completion Date: December 2017
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Participating GPs
GPs working at randomly selected GP centers/offices within the region that are invited to participate and signs a written informed consent to participate. (N=30-40)
Other: Quality improvement intervention
A complex intervention will be implemented within the group of GPs in the intervention group. It includes participation in defining criteria for good referral letters, information about the correlation between information in the referral letters and outcome, introduction to the guideline, and consecutive feedback on own preformance regarding content of referral letter and outcome for the patient.
No Intervention: Control group
GPs working at randomly selected GP centers/office within the region that are not invited to participate, will form the control group. (N=30-40)

Detailed Description:
The study is based on a stepwise progression including four steps. Within step one group interview with four mixed groups of health professionals (both Primary and Specialised Care), patient representatives and managers will be conducted. The groups will give input on firstly, what information they think is important to include in the referral letters, and secondly, what impact they think improved referral letters can have for the organisation and care within Specialised Mental Health Care. Within step two a validated check-list to assess the quality of referral letters will be developed. Within step three outcome measures will be developed and tested. Both step two and three will make use of the results from step one in addition to existing literature and testing. Step four is the intervention study where measures from the former steps will be used.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Referral letters send from a GP to Public Specialised Mental Health Care
  • Referrals for elective assessment or treatment

Exclusion Criteria:

  • Referral letters send from other health personnel
  • Referrals for acute care (within 24 hours)
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01374035


Locations
Norway
Helse Fonna Local Health Authorities
Haugesund, Norway, 5504
Sponsors and Collaborators
Helse Fonna
University of Bergen
Katholieke Universiteit Leuven
Investigators
Study Chair: Aslak B Aslaksen, MD, PhD Faculty of Medicine and Dentistery, University of Bergen, Norway
Principal Investigator: Kjell Haug, MD, PhD Faculty of Medicine and Dentistery, University of Bergen, Norway
Principal Investigator: Kris Vanhaecht, RN, PhD Katholieke Universiteit Leuven
  More Information